Sessions & Session Chairs
Sessions
S1. Multiple Myeloma
S2. Acute Myeloid Leukemia
S3. Acute Lymphoblastic Leukemia
S4. Non-Hodgkin Lymphoma
S5. Hodgkin Lymphoma
S6. CML and Myeloproliferative Neoplasms
S7. Stem Cell Transplantation and New Cellular Therapies
S8. Rare Diseases
IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy
IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, FC, Italy
Giorgia Simonetti got her PhD in Molecular and Translational medicine in 2012 from University Milano-Bicocca. During her PhD and Post-Doc she worked at San Raffaele Scientific Institute, at The Herbert Irving Cancer Center of Columbia University in New York and at University of Bologna, focusing on B-cell malignancies, B-cell immunology and acute leukemias. Currently, she is the Head of the Translational Hematology Unit at IRST since 2019. Her research group focuses on the integration between multi-omics technologies (including but not limited to genomics, transcriptomics, metabolomics, proteomics) aiming to the improvement of disease classification and risk stratification and the identification of subgroups of acute leukemia patients for the identification and preclinical testing (on 2D and 3D models) of novel therapeutics (through pharmacological tests and genetic engineering). She has been recipient of the Non-Clinical junior research fellowship from European Hematology Association (EHA), the Alma Idea Junior Grant from University of Bologna, and she is currently the PI of a My First AIRC grant and the co-PI of a PNRR project.
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy
IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, FC
Giorgia Simonetti got her PhD in Molecular and Translational medicine in 2012 from University Milano-Bicocca. During her PhD and Post-Doc she worked at San Raffaele Scientific Institute, at The Herbert Irving Cancer Center of Columbia University in New York and at University of Bologna, focusing on B-cell malignancies, B-cell immunology and acute leukemias. Currently, she is the Head of the Translational Hematology Unit at IRST since 2019. Her research group focuses on the integration between multi-omics technologies (including but not limited to genomics, transcriptomics, metabolomics, proteomics) aiming to the improvement of disease classification and risk stratification and the identification of subgroups of acute leukemia patients for the identification and preclinical testing (on 2D and 3D models) of novel therapeutics (through pharmacological tests and genetic engineering). She has been recipient of the Non-Clinical junior research fellowship from European Hematology Association (EHA), the Alma Idea Junior Grant from University of Bologna, and she is currently the PI of a My First AIRC grant and the co-PI of a PNRR project.
Hematology Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy
Department of Medical and Surgical Specialties, Department of General Surgery and Medical–Surgical Specialties, Section of Haematology, University of Catania, Catania, Italy
IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) “Dino Amadori”,Meldola, Italy
Hematology, S. Eugenio Hospital, Tor Vergata University, ASL Roma2, Rome, Italy
Department of Hematology and Oncology, Villa Sofia-Cervello Hospital, Palermo, Italy
Hematology Department, Mauriziano Hospital, Turin, Italy, University of Turin, Turin, Italy